AstraZeneca Pharma India informs about appointment of senior management personnel

25 Feb 2025 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Harish Dash as Senior Director, Commercial IT & Digital, with effect from March 3, 2025. In this regard, it has enclosed the details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, attached as Annexure – A.

The above information is a part of company’s filings submitted to BSE.


Astrazeneca Pharma I Share Price

9068.00 125.65 (1.41%)
23-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.90
Dr. Reddys Lab 1185.95
Cipla 1533.55
Lupin 2088.85
Zydus Lifesciences 868.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...